We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Siemens Healthineers - Laboratory Diagnostics

Download Mobile App




Microsampling Device Simultaneously Collects Four Volumetrically Identical DBS Blood Samples

By LabMedica International staff writers
Posted on 16 Jun 2023
Print article
Image: The hemaPEN offers a unique approach to capillary sampling (Photo courtesy of Trajan Scientific)
Image: The hemaPEN offers a unique approach to capillary sampling (Photo courtesy of Trajan Scientific)

A cutting-edge device employing volumetric microsampling with capillary and advanced dried blood spot (DBS) technology can collect four equal-volume DBS blood samples from a single finger prick.

Trajan Scientific and Medical’s (Victoria, Australia) hemaPEN is designed to provide a convenient procedure for collecting and storing four DBS samples, thereby enhancing information-rich decision-making. This user-friendly microsampling device can collect four volumetrically identical capillary samples from a single finger stick. The hemaPEN introduces a unique method of capillary sampling with its four integrated capillary tubes within the device for easier handling. The glass capillaries simultaneously draw four samples from a single finger prick, transferring four blood spots onto a DBS cartridge within the hemaPEN.

Designed for one-time use, the hemaPEN is a low-volume sampling device that can collect a sample from any angle, virtually eliminating the risk of under or over-sampling, which benefits users with restricted mobility. Users appreciate the intuitive pen-like design of the hemaPEN and the ability to swiftly collect four microsamples from just one finger prick. Additionally, the hemaPEN ensures the security of samples. After sample collection, users insert the tip of the hemaPEN into its plastic base and push down until a "click" sound is heard, which seals the hemaPEN and transfers the four capillary samples onto four pre-punched DBS papers inside.

Labs that are already equipped for a DBS workflow should find the transition to hemaPEN microsampling methods smooth. Unlike conventional DBS sampling tools, the hemaPEN allows for the collection of an exact and precise fixed micro-volume and is engineered to maintain sample integrity for quantitative analysis. An advantage of the hemaPEN over traditional DBS cards is that it eliminates the need for aliquoting and hole-punching. This is because the hemaPEN collects the four DBS samples onto four pre-punched, industry-standard DBS filter papers within the device. The hemaPEN is suitable for both manual and automated DBS processing workflows. Trajan also provides the hemaPEN opening tool and hemaPEN-QC to assist labs in processing and analyzing DBS microsamples manually or at high throughput. Trajan has received regulatory approval for the clinical use of hemaPEN in Europe and the United Kingdom.

"Our growing range of microsampling technologies allows almost anyone to take an analytically viable sample outside the clinical setting, anytime, anywhere. In our view, that is essential to enable the healthcare systems of the future," said Stephen Tomisich, CEO and founder of Trajan.

Related Links:
Trajan Scientific and Medical 

New
Platinum Supplier
Automatic Nucleic Acid Workstation
Pana9600X
Gold Supplier
ESR Analyzer
miniiSED™
New
Measles RT Real-Time PCR Test
quanty Measles
New
HIV-1 RNA Linearity Panel
AccuSpan HIV-1 RNA Linearity Panel

Print article
GLOBETECH PUBLISHING LLC

Channels

Clinical Chemistry

view channel
Image: The new assays are designed to run on the B•R•A•H•M•S KRYPTOR compact PLUS clinical chemistry analyzer (Photo courtesy of Thermo Fisher)

Breakthrough Immunoassays to Aid in Risk Assessment of Preeclampsia

Preeclampsia is a life-threatening blood pressure condition that can arise during pregnancy and the postpartum phase. This severe pregnancy complication is a primary cause of maternal and fetal mortality... Read more

Molecular Diagnostics

view channel
Image: A CRISPR technology-based diagnostic test detects MPXV in clinical samples with acute precision (Photo courtesy of 123RF)

Powerful Diagnostic Tool Accurately Detects Monkeypox Virus Faster Than Any Method

At present, testing for the monkeypox virus (MPXV) is done mainly in centralized labs, and it can take days to get results due to location and logistical issues. Now, researchers have leveraged cutting-edge... Read more

Hematology

view channel
Image: The US FDA has cleared HemoScreen point of care CBC for direct capillary sampling (Photo courtesy of PixCell Medical)

Point of Care CBC Analyzer with Direct Capillary Sampling Enhances Ease-of-Use and Testing Throughput

The world’s only 5-part differential Complete Blood Count (CBC) analyzer that is FDA-cleared, CE-marked, and TGA-approved for point-of-care use has now been granted FDA 510(k) clearance for direct capillary... Read more

Immunology

view channel
Image: Immune cells present long before infection predict flu symptoms (Photo courtesy of Shutterstock.com)

Single Blood Draw to Detect Immune Cells Present Months before Flu Infection Can Predict Symptoms

For decades, if not centuries, scientists have struggled to solve the mystery of why certain individuals fall ill to infections while others remain unaffected. In an impressive development, researchers... Read more

Microbiology

view channel
Image: The rapid diagnostic test could pinpoint the correct antibiotic for infection treatment in under an hour (Photo courtesy of Microplate Dx)

Point-of-Care Device to Reduce Antibiotic Susceptibility Testing Time from Days to Minutes

Antimicrobial resistance (AMR) is a significant global health issue, currently leading to over 1.27 million deaths worldwide each year. By 2050, AMR could be causing up to 10 million deaths annually, surpassing... Read more

Technology

view channel
Image: A new electrochemical device can quickly and inexpensively identify people at greatest risk for osteoporosis (Photo courtesy of ACS Central Science, 2023)

Electrochemical Device Identifies People at Higher Risk for Osteoporosis Using Single Blood Drop

With the global increase in life expectancy, the incidence of age-related conditions like osteoporosis is increasing. Osteoporosis, affecting around 200 million individuals worldwide, has a higher incidence... Read more

Industry

view channel
Image: The global fully automatic electrolyte analyzers market is projected to reach close to USD 0.77 billion by 2032 (Photo courtesy of 123RF)

Global Fully Automatic Electrolyte Analyzers Market Driven by Surge in Demand for Point-of-Care Testing

Fully automatic electrolyte analyzers can measure the levels of electrolytes in various bodily fluids like blood and plasma. Electrolytes are ions that have an electrical charge and are essential for multiple... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.